These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 10751750

  • 1. Advanced glycosylation end products (AGEs), insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 (IGFBP-3) in patients with type 2 diabetes mellitus.
    Garay-Sevilla ME, Nava LE, Malacara JM, Wróbel K, Wróbel K, Pérez U.
    Diabetes Metab Res Rev; 2000; 16(2):106-13. PubMed ID: 10751750
    [Abstract] [Full Text] [Related]

  • 2. Relationship between non-enzymatic glycosylation and changes in serum insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 levels in patients with type 2 diabetes mellitus.
    Cortizo AM, Lee PD, Cédola NV, Jasper H, Gagliardino JJ.
    Acta Diabetol; 1998 Jul; 35(2):85-90. PubMed ID: 9747960
    [Abstract] [Full Text] [Related]

  • 3. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
    Jehle PM, Jehle DR, Mohan S, Böhm BO.
    J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
    [Abstract] [Full Text] [Related]

  • 4. The IGF-I system and the renal and haemodynamic effects of losartan in normotensive patients with type 2 diabetes mellitus: a randomized clinical trial.
    Zandbergen AA, Lamberts SW, Baggen MG, Janssen JA, Boersma E, Bootsma AH.
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):203-8. PubMed ID: 16430721
    [Abstract] [Full Text] [Related]

  • 5. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes.
    Frystyk J, Skjaerbaek C, Vestbo E, Fisker S, Orskov H.
    Diabetes Metab Res Rev; 1999 Feb; 15(5):314-22. PubMed ID: 10585616
    [Abstract] [Full Text] [Related]

  • 6. Insulin-like growth factors and binding proteins in patients with recent-onset type 1 (insulin-dependent) diabetes mellitus: influence of diabetes control and intraportal insulin infusion.
    Shishko PI, Dreval AV, Abugova IA, Zajarny IU, Goncharov VC.
    Diabetes Res Clin Pract; 1994 Aug; 25(1):1-12. PubMed ID: 7530621
    [Abstract] [Full Text] [Related]

  • 7. Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus.
    Janssen JA, Jacobs ML, Derkx FH, Weber RF, van der Lely AJ, Lamberts SW.
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2809-15. PubMed ID: 9284701
    [Abstract] [Full Text] [Related]

  • 8. Use of the ligand immunofunctional assay for human insulin-like growth factor ((IGF) binding protein-3 (IGFBP-3) to analyze IGFBP-3 proteolysis and igf-i bioavailability in healthy adults, GH-deficient and acromegalic patients, and diabetics.
    Lassarre C, Duron F, Binoux M.
    J Clin Endocrinol Metab; 2001 May; 86(5):1942-52. PubMed ID: 11344189
    [Abstract] [Full Text] [Related]

  • 9. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients?
    Lindgren BF, Odar-Cederlöf I, Ericsson F, Brismar K.
    Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646
    [Abstract] [Full Text] [Related]

  • 10. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM, Ostertag A, Schulten K, Schulz W, Jehle DR, Stracke S, Fiedler R, Deuber HJ, Keller F, Boehm BO, Baylink DJ, Mohan S.
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [Abstract] [Full Text] [Related]

  • 11. Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure.
    Houang M, Cabrol S, Perin L, Ducos B, Bensman A, Le Bouc Y.
    Growth Horm IGF Res; 2000 Dec; 10(6):332-41. PubMed ID: 11161964
    [Abstract] [Full Text] [Related]

  • 12. Serum insulin-like growth factors and their binding proteins in children with end-stage renal disease.
    Tönshoff B, Blum WF, Mehls O.
    Pediatr Nephrol; 1996 Jun; 10(3):269-74. PubMed ID: 8792388
    [Abstract] [Full Text] [Related]

  • 13. Insulin-like growth factor-1 and its binding proteins, IGFBP-1 and IGFBP-3, in adolescents with type-1 diabetes mellitus and microalbuminuria.
    Wedrychowicz A, Dziatkowiak H, Nazim J, Sztefko K.
    Horm Res; 2005 Jun; 63(5):245-51. PubMed ID: 15920342
    [Abstract] [Full Text] [Related]

  • 14. Low circulating levels of insulin-like growth factor binding protein-1 (IGFBP-1) are closely associated with the presence of macrovascular disease and hypertension in type 2 diabetes.
    Heald AH, Siddals KW, Fraser W, Taylor W, Kaushal K, Morris J, Young RJ, White A, Gibson JM.
    Diabetes; 2002 Aug; 51(8):2629-36. PubMed ID: 12145180
    [Abstract] [Full Text] [Related]

  • 15. Changes in free insulin-like growth factor-1 and leptin concentrations during acute metabolic decompensation in insulin withdrawn patients with type 1 diabetes.
    Attia N, Caprio S, Jones TW, Heptulla R, Holcombe J, Silver D, Sherwin RS, Tamborlane WV.
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2324-8. PubMed ID: 10404797
    [Abstract] [Full Text] [Related]

  • 16. Insulin-like growth factor I, binding proteins -1 and -3, risk of type 2 diabetes and macronutrient intakes in men.
    Similä ME, Kontto JP, Virtamo J, Hätönen KA, Valsta LM, Sundvall J, Männistö S.
    Br J Nutr; 2019 Apr; 121(8):938-944. PubMed ID: 30898176
    [Abstract] [Full Text] [Related]

  • 17. Reduced IGFBP-1 is associated with thickening of the carotid wall in type 2 diabetes.
    Leinonen ES, Salonen JT, Salonen RM, Koistinen RA, Leinonen PJ, Sarna SS, Taskinen MR.
    Diabetes Care; 2002 Oct; 25(10):1807-12. PubMed ID: 12351482
    [Abstract] [Full Text] [Related]

  • 18. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P, Díez JJ, Fernández-Reyes MJ, Méndez J, Bajo MA, Aguilera A, Selgas R.
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
    [Abstract] [Full Text] [Related]

  • 19. The correlation between insulin-like growth factor with glycemic control, glomerular filtration rate, blood pressure, hematological changes or body mass index in patients with type 2 diabetes mellitus.
    NeamŢu MC, Avramescu ET, Marcu IR, Turcu-Ştiolică A, Boldeanu MV, NeamŢu OM, Tudorache Ş, Dănciulescu Miulescu RE.
    Rom J Morphol Embryol; 2017 Jun; 58(3):857-861. PubMed ID: 29250665
    [Abstract] [Full Text] [Related]

  • 20. Insulin-like growth factor binding protein-1 in NIDDM: relationship with the insulin resistance syndrome.
    Mohamed-Ali V, Pinkney JH, Panahloo A, Cwyfan-Hughes S, Holly JM, Yudkin JS.
    Clin Endocrinol (Oxf); 1999 Feb; 50(2):221-8. PubMed ID: 10396366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.